Pangolin Therapeutics, Inc.
A novel chemistry platform that targets toxic protein mis‑assembly in neurodegenerative and metabolic diseases. The initial focus of the Pangomer approach is on neurodegenerative diseases, including Parkinson’s and Alzheimer’s. There are many opportunities for expansion into other classes of disease. A Pangomer analogue optimized for selectivity to non-amyloid forms of islet amyloid polypeptide (IAPP) shows good pharmacological properties in a mouse model of Type II Diabetes.pangolintherapeutics.com
Inaccurate data? Flag it here.
Open jobs at Pangolin Therapeutics, Inc.
This company does not have jobs relevant to this job board at this time.
To view all their jobs, visit their website.